Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.24.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred income taxes at December 31, 2023 and 2022 are shown below (table in thousands):

 

    2023     2022  
Deferred tax assets:                
Net operating loss carryforwards   $ 22,005     $ 21,368  
Compensation     583       474  
Research and development tax credits     3,196       2,710  
Capitalized and Research Expenditures     5,288       2,595  
Other     848       487  
Total deferred tax assets     31,920       27,633  
                 
Deferred tax liabilities:                
Property and equipment     (29 )     (27 )
Other     (410 )     (60 )
Total deferred tax liabilities     (439 )     (87 )
                 
Total deferred taxes, net     31,481       27,546  
Valuation allowance     (31,481 )     (27,546 )
                 
Deferred tax liability, net   $ -     $ -  
Schedule of Reconciliation of Federal Statutory Income Tax Rate

A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

    2023          2022        
             
Statutory federal income tax rate     21.0 %     21.0 %
Goodwill impairment     0.0 %     (10.3 )%
Research credits     2.8 %     0.7 %
Change in valuation allowance     (21.9 )%     (10.2 )%
Equity     (0.4 )%     (1.4 )%
Other tax, credit and adjustments     (1.5 )%     0.2 %
Effective income tax rate     0.0 %     0.0 %